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Original article 
 
Diagnosis of pulmonary tuberculosis among asymptomatic HIV+ 
patients in Guangxi, China 
 
ZHANG Yao, YU Lan, TANG Zhi-rong, HUANG Shao-biao, ZHENG Yuan-jia, MENG Zhi-hao,  
SUN Kai, WANG Li-ming, Ray Y. CHEN and ZHANG Fu-jie 
 
Keywords: tuberculosis; human immunodeficiency virus; diagnosis 
 
Background  Pulmonary tuberculosis (PTB) among asymptomatic Chinese patients with HIV infection has not been 
investigated despite high tuberculosis burden in China. This study was aimed to evaluate the prevalence, risk factors and 
clinical outcomes of PTB among asymptomatic patients with HIV/AIDS in Guangxi to facilitate the development of 
diagnostic and treatment strategies. 
Methods  All asymptomatic adult HIV-infected patients with CD4 <350 cells/µl who attended four HIV clinics in Guangxi 
between August 2006 and March 2008 were evaluated for active PTB with physical examination, chest X-ray (CXR), 
sputum smear and/or sputum liquid culture. Data were described using median (interquartile range, IQR) and frequencies. 
Univariate and multivariate Logistic regression analyses were performed to identify risk factors associated with PTB.   
Results  Among 340 asymptomatic subjects, 15 (4%) were diagnosed with PTB, with 4 (27%) sputum smear positive 
and 8 (53%) sputum culture positive. CXR has higher diagnostic sensitivity (87%) than sputum smear (25%) and sputum 
culture (67%), but lower specificity (56%) compared with sputum smear (99%) and culture (100%). In univariate analysis, 
injection drug user, body mass index (BMI) <18 kg/m2, CD4 <50 cells/µl and presence of peripheral lymphadenopathy 
were associated with an increased risk of asymptomatic PTB, while in multivariate analysis only peripheral 
lymphadenopathy maintained statistical significance (OR=7.6, 95% CI 1.4–40). Patients with negative smear and minor 
or no abnormalities on CXR had longer interval between screening and TB treatment.  
Conclusions  PTB was relatively common in this group of HIV+ asymptomatic Chinese patients. Diagnosis is 
challenging especially where sputum culture is unavailable. These findings suggest that an enhanced evaluation for PTB 
needs to be integrated with HIV care in China and transmission prevention in China to control at both households and 
health care facilities, especially for patients with factors associated with a higher risk of PTB.   
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uberculosis (TB) is endemic in many developing 
countries including China and is a major cause of 
morbidity and mortality in people living with 
HIV/AIDS.1-5 Both asymptomatic and subclinical 
pulmonary TB (PTB) are relatively common among HIV+ 
patients in TB endemic areas, and undiagnosed TB is a 
key cause of the immune reconstitution inflammatory 
syndrome, but the most effective TB diagnostic strategy 
in the developing country setting is not clear.6-9 The 
World Health Organization (WHO) recommends sputum 
smear microscopy in all HIV patients with clinical 
features suggestive of PTB, with follow-up chest X-ray 
(CXR) if sputum smear is negative,10 but this algorithm is 
limited by poor sensitivity.11,12 In developed countries 
like the United States, CXR, sputum smear and culture 
are all included in the evaluation of suspected PTB.13 
However, neither of these approaches addresses 
asymptomatic persons. By definition, asymptomatic PTB 
is a diagnosis based on positive radiologic and/or 
microbiologic evidence with a negative symptom 
screening, while the diagnosis of subclinical PTB is based 
on positive culture and/or smear without any CXR or 
symptom findings. Mtei et al8 reported that in Tanzania 
the prevalence of subclinical TB and asymptomatic TB 
were 4.3%, and 9.6%, respectively. A study from South 
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India showed that 4% of asymptomatic HIV positive 
individuals with normal chest radiograph and negative 
sputum smears had positive sputum cultures for M. 
tuberculosis.9 Among HIV-infected gold miners in South 
Africa, PTB was diagnosed in 2.7% of asymptomatic 
patients.7 Given the high background prevalence of 
tuberculosis, Chinese guidelines suggest an annual CXR 
and sputum smear examination in all HIV+ patients 
regardless of symptoms, although this strategy has not 
been compared with recommendations from other 
countries.14 
 
Assessing for PTB in asymptomatic HIV+ patients is of 
public health and clinical importance because a missed 
TB diagnosis is associated with adverse consequences 
due to delayed or absent treatment.8,15 In addition, 
initiating antiretroviral therapy (ART) with an 
undiagnosed TB infection may result in rapid 
deterioration due to TB-associated immune reconstruction 
inflammatory syndrome, which is particularly important 
during antiretroviral therapy scaling-up programs.16,17 
Finally, without prompt treatment, the risk of household 
and nosocomial transmission of TB is significantly 
increased.   
 
The purpose of this study is to evaluate the prevalence, 
risk factors and clinical outcomes of PTB among 
asymptomatic patients with HIV/AIDS in Guangxi, China 
to facilitate the development of diagnostic and treatment 
strategies. 
 
METHODS 
 
Study subjects and protocol 
HIV positive patients at least 18 years old and receiving 
routine HIV outpatient care at 4 sites (Nanning 4th 
People’s Hospital, Longtan Hospital, Liuzhou CDC 
Clinic, and Guangxi CDC Clinic) in Guangxi Zhuang 
Autonomous Region from August 2006 to March 2008 
were eligible for this study. After informed consent, 
patients were administered a TB symptom questionnaire 
regarding the presence and duration of cough, sputum 
production, hemoptysis, dyspnea, chest pain, night sweats, 
fatigue, fever and subjective weight loss in the past 6 
months. Patients received CD4 count testing if not 
performed within the previous two months. Symptomatic 
patients were not included in this analysis. Patients 
without any of the above symptoms and with CD4 count 
less than 350 cells/µl were invited to undergo PTB 
screening with a posterior-anterior CXR and acid-fast 
bacilli (AFB) stain and liquid culture from up to 3 sputum 
specimens. CXR was interpreted and described in detail 
by radiologists at each study site. Attempts were made to 
obtain three self-produced sputum samples for smear and 
culture, one at the time of clinic visit, one in the evening, 
and one upon first awakening in the morning. For patients 
who received repeated TB screening at subsequent 
follow-up visits, only the initial evaluation was included 
in this analysis. Those diagnosed with PTB were 
scheduled for standard follow up visits at 0.5, 1, 2, and 3 
months after enrollment and once every 3 months 
thereafter. This study was approved by the institutional 
review board of the Chinese Centers for Disease Control 
and Prevention. 
 
Laboratory methods 
Sputum was digested and decontaminated with 
N-acetylcysteine and concentrated by centrifugation. 
Ziehl-Neelson staining was used for sputum smear. 
Culture was conducted in BacT/Alert MP liquid culture 
media using the BacT/Alert 3D automated detection 
system (BioMerieux, Marcy L’Etoile, France). 
Mycobacterial speciation was conducted using gold 
immunochromatography assay. 
 
Case definitions 
Patients were identified as having PTB if they had either: 
(1) at least one positive sputum culture for M. 
tuberculosis or positive sputum smear for AFB; or (2) 
radiological features consistent with PTB infection, no 
response to 5 days of broad spectrum antibiotics, and 
improvement after empiric TB treatment. Patients 
suspected of concomitant extrapulmonary TB infection 
were administered additional testing as clinically 
indicated, and culture, AFB smear and pathology studies 
were performed on relevant specimen samples. When 
microbiologic or pathologic studies were negative and 
extrapulmonary TB was still suspected, empiric diagnosis 
was made by the failure to respond to broad spectrum 
antibiotics and subsequent improvement on TB specific 
therapy.    
 
Statistical analysis 
Medians (interquartile range, IQR) and frequencies (%) 
were used to describe the patient characteristics. 
Categorical variables were compared using chi-square or 
Fisher’s exact tests as indicated. Continuous variables 
were compared using the Mann-Whitney U test. Analysis 
of clinical and demographic factors associated with PTB 
was performed for all patients who underwent all three 
examinations (CXR, sputum smear and culture) to avoid 
bias associated with the likelihood of performing a test. 
Factors considered clinically relevant and associated with 
PTB diagnosis in univariate Logistic regression (P <0.10) 
were included in the multivariate model. A two-side P 
value <0.05 was considered statistically significant. 
Statistical analyses were performed using STATA 
(Version 9.1, College Station, TX. USA). 
 
RESULTS 
 
Between August 2006 and Decbmer 2008, 514 asympto- 
matic HIV-infected individuals were identified based on 
negative symptom questionnaires. Of these, 18 patients 
with known active PTB undergoing treatment at the time 
of enrollment were excluded. Among the remaining, 359 
had CD4 count less than 350 cells/µl and were invited for 
further PTB evaluation with CXR, sputum smear 
Chin Med J 2010;123(23):3400-3405 3402 
Table 1. Characteristics of 15 asymptomatic HIV-infected subjects with PTB 
Patients 
CD4 cell count 
(cells/µl) 
On 
ART 
BMI 
(kg/m2) 
Lymph- 
adenopathy 
Chest X-ray 
Sputum 
smear
Sputum
culture 
Interval from screening 
to treatment (days) 
Extrapulmonary 
TB 
Survival after 1 year 
from screening 
1 204 Yes 17.1 − Upper lobe infiltrates, 
increased lung markings 
+ + 89 
− 
No 
2 180 No 22.2 + Lower lobe infiltrates + + 14 − Yes 
3 114 Yes 21.7 + Increased lung markings − + 3 + Yes 
4 27 Yes 17.4 + Increased lung markings Nil Nil 91 + Yes 
5 249 Yes 22.1 − Right lower lobe infiltrates Nil Nil 36 − Yes 
6 8 Yes 16.6 + Right lower lobe infiltrates − − 30 − No 
7 14 No 17.9 + Left lower lobe infiltrates − − 1 + No 
8 280 No 19.1 − No abnormalities − + 105 − Yes 
9 56 Yes 21.1 
− Right middle lobe infiltrate, 
hilar lymphadenopathy 
+ Nil 1 
− 
Yes 
10 16 Yes 17.9 − No abnormalities + + 58 − Yes 
11 12 Yes 17.6 − Left side pleural effusion − − 1 − Loss 
12 10 Yes 20.1 − Increased lung markings − + Died before Tx − No 
13 229 No 13.8 − Increased lung markings − + Died before Tx − No 
14 2 Yes 18.4 − Increased lung markings − + 174 − No 
15 26 Yes 20.6 − Bilateral scattered infiltrates − − 17 − Yes 
Patients 3 and 7 died before TB treatment. Tx: treatment. 
 
and sputum culture. Nineteen patients declined to join the 
study, leaving 340 participants. All but one patient had 
CXR results. Although 156 (46%) and 130 (38%) 
individuals provided sputum specimens for AFB smear 
and sputum culture, respectively, only 128 (38%) had 
both, and 127 (37%) had all three recommended 
examinations. 
 
Among the 340 included patients, active PTB was 
diagnosed in 15 (4%) patients (Table 1), of which 8 (53%) 
had positive sputum cultures, 4 (27%) had positive AFB 
smears, and 6 were diagnosed solely based on clinical 
features. The median age was 32 years (range 26–56), 9 
(67%) were male, and median CD4 count at screening 
was 27 cells/µl (range 2–280 cells/µl). Five patients 
diagnosed with PTB had peripheral lymphadenopathy, 
among them three were diagnosed with TB lymphadenitis. 
Other forms of extrapulmonary TB were found in this 
study. 
 
Among PTB cases, increased lung markings was the most 
frequently reported radiographic abnormality (40%), 
followed by lower lobe infiltrates (27%) and normal CXR 
(13%). Upper lobe infiltrates and left sided pleural 
effusion were each seen in one patient. No one was found 
to have pulmonary cavitation. Among 8 patients with 
normal or increased lung markings on CXR, 6 had 
positive sputum cultures, but only 1 was smear-positive. 
Among a total of 8 culture positive TB cases, only 3 
(37%) were smear-positive. A total of 5 smear positive 
cases were identified, with one (20%) later determined to 
be a non-tuberculosis mycobacterium (NTM). Based on 
the 127 patients who underwent all recommended 
workups (CXR, sputum smear and sputum culture), the 
sensitivity was 87% for any abnormal CXR, 67% for a 
positive sputum culture, and 25% for a positive sputum 
AFB smear. The specificities of an abnormal CXR and 
positive sputum smear were 56% and 99%, respectively. 
NTM was identified in 4 (3%) individuals with sputum 
culture.  
Among the 15 patients diagnosed with PTB in this study 
at one year, 8 were still alive, 1 was lost to follow-up, and 
6 had died, giving a one-year mortality rate of 40%. PTB 
patients with normal CXR or only increased lung 
markings and negative sputum smears experienced 
significant delay between screening and treatment 
(median 105 days), compared to patients with more 
prominent CXR findings or positive sputum smear 
(median 17 days, P=0.01). Two patients died before 
treatment initiation, both of whom had negative sputum 
smears and normal or increased lung markings on chest 
radiography at screening. Given the limited sample size, 
Logistic regression analysis for risk factors for mortality 
was not performed. 
 
Based on the 127 patients who had all three evaluations, 
baseline demographic, laboratory and clinical characteri- 
stics were compared between those with and without PTB 
(Table 2). In univariate analyses, injection drug use (IDU), 
body mass index (BMI) <18 kg/m2, CD4 <50 cells/µl and 
presence of peripheral lymphadenopathy were associated 
with increased risk of asymptomatic PTB, while in 
multivariate analyses only peripheral lymphadenopathy 
maintained statistical significance (OR=7.8, 95% CI 
1.4–42). Among 18 patients who had peripheral 
lymphadenopathy, 5 (28%) had PTB, compared to 7 (3%) 
among 322 participants without peripheral lympha- 
denopathy.  
 
DISCUSSION 
 
Symptomatic screening has been shown to be fairly 
effective in ruling out TB. In the recent study by Cain et 
al,12 a combination of three symptom predictors was 97% 
effective in ruling out active TB. However, that still left 
3% of patients in their study and 4% of patients in our 
study who were asymptomatic but still had active TB. In 
TB-endemic locales, this can still translate into a large 
amount of morbidity and mortality, especially with 
subsequent secondary infections. This finding highlights  
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Table 2. Comparison of subjects with and without PTB 
Characteristics Subjects without PTB 
(n=115)  
Subjects with PTB 
(n=12) 
P values  
(univariate regression analysis) 
OR (95% CI)  
(multivariate regression analysis)
Age (median (IQR), years) 35 (28–44) 36 (31–47) 0.850 NS 
Male (n (%)) 65 (57) 7 (58) 0.900 NS 
Injection drug use (n (%)) 33 (29) 7 (58) 0.040 NS 
Contact history of TB (n (%)) 2 (2) 0 (0) * NS 
BMI <18 kg/m2 (n (%)) 25 (22) 6 (50) 0.030 NS 
Lymphadenopathy (n (%)) 5 (4.3) 5 (42) 0.005 7.8 (1.4–42.0) 
CD4 at screening <50 cells/µl (n (%)) 32 (28) 7 (58) 0.045 NS 
On ART (n (%)) 98 (85) 8 (67) 0.100 NS 
*Not included in the analysis since only 2 subjects reported TB contact history. IQR: interquartile range. NS: no significance. PTB: pulmonary tuberculosis. 
 
the importance of being vigilant when caring for HIV 
infected patients in TB endemic areas, even when patients 
are asymptomatic.  
 
Identifying a test with appropriate sensitivity and 
specificity to diagnose PTB among asymptomatic 
HIV-infected individuals is difficult. Because our patients 
were asymptomatic, sputum AFB smear was only 25% 
sensitive, lower than previous estimates (31%–80%),6 but 
99% specific. Because of this low sensitivity, sputum 
culture is needed but even this was only 67% sensitive in 
our study. Among all patients with positive sputum 
culture, 4 yielded NTM and 8 M. tuberculosis, suggesting 
that NTM infection or colonization is relatively common 
in this study population.3 CXR had the highest sensitivity 
(87%) in our study but lower specificity (56%) in 
diagnosing PTB in our study compared with sputum 
smear and culture. Typical CXR findings for PTB, such 
as upper lobe infiltrate or cavitation, were present in only 
one case. Thus, CXR alone as well was insufficient for 
diagnosis in our study, consistent with previous 
reports.18,19 Our data reinforce the concept that among 
asymptomatic HIV+ patients, neither sputum smear or 
CXR alone, nor their combination is sufficient for 
diagnosing PTB.6 Sputum culture is still necessary to 
improve diagnostic yield but the importance of clinical 
vigilance and close follow-up cannot be overstated. 
 
We identified several factors associated with active PTB 
in the study population. Univariate analysis showed that 
patients with a history of IDU, BMI <18 kg/m2, and CD4 
<50 cells/µl were more likely to be diagnosed with PTB, 
consistent with risk factors from other studies.20-24 
Peripheral lymphadenopathy was also associated with 
higher risk for PTB and remained the only statistically 
significant risk factor in the multivariate analysis. The 
association with IDU compared to other exposure groups 
(mostly heterosexual transmission) is likely due to a 
higher background prevalence of latent TB infection and 
social or lifestyle factors resulting in more frequent 
exposure. Consistent with finding of a previous study,8 
our participants with peripheral lymphadenopathy had 
close to an 8-fold higher risk for PTB. Since TB is a 
major cause of enlarged lymph nodes in HIV infected 
populations in developing countries,25,26 we speculate that 
this association is mainly attributable to a common 
etiology for pulmonary and lymph node involvement. 
This finding helps us identify a sub-group of higher risk 
patients on whom to focus intervention efforts. 
     
Notably, 40% (6/15) of these asymptomatic PTB patients 
died within one year of enrollment. Studies have shown 
that multiple factors contribute to high mortality among 
patients with HIV/TB co-infection, including delayed TB 
diagnosis and treatment, infection with drug resistant TB, 
delayed or absent ARV therapy, advanced 
immunosuppression and certain baseline demographic 
characteristics.27-31 Our study was unfortunately not 
powered to investigate the role of individual factors. We 
do show, however, that without an abnormal CXR or AFB 
positive sputum smear, TB diagnosis and treatment was 
significantly delayed or totally absent among these 
asymptomatic patients. Among the 5 patients with an 
AFB negative sputum smear but subsequent positive 
sputum culture, 2 (40%) died before TB treatment was 
initiated.  
 
Overall, we found a 4.4% prevalence of PTB among 
asymptomatic HIV+ Chinese patients with advanced 
immunosuppression (CD4 <350 cells/µl), and 67% of the 
cases were culture positive. The relatively high 
prevalence of PTB in asymptomatic HIV+ patients found 
in this study has several implications that are in line with 
the WHO recommendations regarding TB control. First, it 
reinforces the idea that in TB endemic areas even among 
asymptomatic patients, intensified case finding of TB 
should be prioritized in HIV+ people with CD4 <350 
cells/µl. This heightened vigilance is particularly relevant 
to the recommended roll-out of INH preventive treatment 
among HIV infected patients in TB endemic settings,10 as 
INH monotherapy may induce resistance in patients with 
active TB. Second, symptom-based diagnostic 
approaches will miss a number of PTB cases among 
HIV+ patients with advanced immunodeficiency. 
However, until simpler, cheaper and more accurate 
diagnostics are developed and validated, we will still rely 
on the combination of available radiological and 
microbiological tests and clinical judgment, especially 
before initiating antiretroviral therapy. Providers in rural 
healthcare settings should familiarize themselves with the 
strengths and shortcomings of these available tools so as 
to use them properly. Third, strategies must be 
implemented to prevent TB transmission within 
households and healthcare settings. In this study, 53% of 
diagnosed PTB cases were sputum culture positive and 
33% sputum smear positive, while the median interval 
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from screening to treatment was prolonged at 4 weeks, 
conferring considerable risk of transmission. Well 
established and simple methods of infection control 
including patient education, frequent ventilation, case 
isolation and using reliable protective masks are 
paramount and should be appropriately utilized.  
 
There are several limitations to our work. First, the 
overall prevalence of PTB was likely underestimated in 
our study because 46% of participants declined to provide 
sputum specimens for smear and culture and, among 
those who provided sputum samples, only 37% provided 
three. This underestimation, although further under- 
powering our study to find relevant risk factors, does not 
change the result that we did find of lymphadenopathy 
being significantly associated with PTB. Had this study 
been less under-powered, we may have been able to 
identify more risk factors. Second, the locations of 
involved lymph nodes were not recorded in this study, so 
we were not able to distinguish generalized from 
localized lymphadenopathy. While localized lymph node 
enlargement is frequently caused by TB and associated 
with pulmonary involvement, generalized 
lymphadenopathy is more likely to be related to the HIV 
infection itself. Lastly, tuberculin skin testing (TST) was 
not performed in this study, so we could not evaluate the 
diagnostic value of this widely available test. Studies 
have demonstrated that tuberculin positivity is related to 
active TB,32,33 and thus can be used to further stratify risk 
groups for PTB.  
 
The intersecting epidemics of TB and HIV present a 
serious public health problem in China. Liquid sputum 
culture is currently the gold standard for TB diagnosis. 
However, the cost, long cultivation period and associated 
delay of treatment all hinder its use in resource limited 
settings such as rural China, which truly emphasizes the 
need for more rapid and available diagnostic tools. Given 
the serious consequences of undiagnosed TB, we propose 
that extended evaluation for PTB should be performed 
among asymptomatic Chinese patients with HIV 
prioritizing those with relevant risk factors, such as 
peripheral lymphadenopathy. Larger studies need to be 
done to identify additional risk factors among this cohort 
that can help identify those at the highest risk of active 
TB infection. Subsequent prevention of secondary 
transmission at the levels of the households and health 
care facilities can then also be applied.  
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